Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on July 18, 2025

6th TimePie Longevity Forum: A Global Gateway to China’s 1.4 Billion Anti-Aging Opportunities

6th TimePie Longevity Forum: A Global Gateway to China’s 1.4 Billion Anti-Aging Opportunities

From science to solution, from policy to practice. SINGAPORE, July 18, 2025 /⁨EINPresswire.com⁩/ -- As China’s population ages rapidly, the development of the longevity industry has been prioritized to the level of national strategy since 2024. To …

Rooting out plant diseases: Research suggests computers aren't ready to run our farms

Rooting out plant diseases: Research suggests computers aren't ready to run our farms

DARWIN, NORTHERN TERRITORY, AUSTRALIA, July 18, 2025 /⁨EINPresswire.com⁩/ -- Nature is still too complex for artificial intelligence (AI) modelling to be effective, but the tipping point is close, according to a new study that found the technology may …

MOONTON Games partners The Little Black Book Studios and Base Media to develop animated series for Mobile Legends

MOONTON Games partners The Little Black Book Studios and Base Media to develop animated series for Mobile Legends

The series will feature the same award-winning animation team behind Ne Zha 2 SINGAPORE, CHINA, July 18, 2025 /⁨EINPresswire.com⁩/ -- MOONTON Games, the global developer and publisher of the hit mobile Multiplayer Online Battle Arena (MOBA) game Mobile …

Norsk Hydro: Frivillig oppsigelse av kraftavtale med Cloud Snurran AB

Norsk Hydro: Frivillig oppsigelse av kraftavtale med Cloud Snurran AB

Hydro har inngått et forlik angående en langsiktig kraftkjøpsavtale (PPA) med Cloud Snurran AB. I forliket har Hydro rett til en kompensasjon på opptil 90 millioner euro for sin frivillige oppsigelse av avtalen.  Hydro Energi AS inngikk i 2018 en PPA med …

Norsk Hydro: Voluntary termination of power purchase agreement with Cloud Snurran AB

Norsk Hydro: Voluntary termination of power purchase agreement with Cloud Snurran AB

Hydro has agreed to a settlement for the long-term power purchase agreement (PPA) with Cloud Snurran AB. In the settlement, Hydro is entitled to compensation of up to EUR 90 million for its voluntary termination of the PPA.  Hydro Energi AS signed a long- …

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research …

Press Release: Sanofi completes acquisition of Blueprint Medicines

Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, and …

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Sanofi finalise l’acquisition de Blueprint Medicines Paris, le 18 juillet 2025. Sanofi annonce aujourd’hui la finalisation de l’acquisition de Blueprint Medicines Corporation (Blueprint). La nouvelle entreprise ajoute au portefeuille de Sanofi des …

FACT CHECK: Frequency Holdings YCRM Issues Clarification On Procedural Judgment; No Liability to Company, Litigation Exposure Remains for Luciano Aguayo

FACT CHECK: Frequency Holdings YCRM Issues Clarification On Procedural Judgment; No Liability to Company, Litigation Exposure Remains for Luciano Aguayo

CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Frequency Holdings Inc. (OTC: YCRM), a Nevada public company, issues this clarification following a press release distributed on July 17, 2025, by Luciano Aguayo, defendant in the original and now-defunct lawsuit …

Aduro Clean Technologies tritt der Plastics Industry Association und der Polystyrene Recycling Alliance zur Förderung der Branchenzusammenarbeit im Bereich Recycling-Innovationen bei

Aduro Clean Technologies tritt der Plastics Industry Association und der Polystyrene Recycling Alliance zur Förderung der Branchenzusammenarbeit im Bereich Recycling-Innovationen bei

LONDON, Ontario, July 18, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für saubere Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie …

Aduro Clean Technologies rejoint la Plastics Industry Association et la Polystyrene Recycling Alliance en vue de favoriser la collaboration entre les industries en matière d’innovation dans le domaine du recyclage

Aduro Clean Technologies rejoint la Plastics Industry Association et la Polystyrene Recycling Alliance en vue de favoriser la collaboration entre les industries en matière d’innovation dans le domaine du recyclage

LONDON, Ontario, 18 juill. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (ci-après « Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société de technologie propre qui recycle chimiquement les matières premières de moindre …

SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients

SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients

Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu), a wholly owned …

Successful Commercial Launch of Ryoncil®

Successful Commercial Launch of Ryoncil®

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil® (remestemcel-L-rknd) through the first …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service